Gail McIntyre's most recent trade in Aravive Inc was a trade of 700,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 1, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Aravive Inc | Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
Aravive Inc | Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.92 per share. | 24 Oct 2022 | 54,353 | 65,490 (0%) | 0% | 0.9 | 49,999 | Common stock |
Aravive Inc | Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 27,177 | 27,177 | - | - | Series A Warrants (right to buy) | |
Aravive Inc | Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 27,176 | 27,176 | - | - | Series B Warrants (right to buy) | |
Aravive Inc | Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 425,000 | 425,000 | - | - | Stock Option (Right to buy) | |
Aravive Inc | Gail McIntyre | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 5.34 per share. | 29 Jun 2021 | 1,000 | 11,137 (0%) | 0% | 5.3 | 5,345 | Common Stock |
Aravive Inc | Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 165,000 | 165,000 | - | - | Stock Options |